Exome sequencing of patients with extreme toxicities to uncover pharmacogenomics of 5-fluorouracil-based chemotherapeutics in colorectal cancer

被引：0
|
作者：
Simoes, Ana [1 ]
Lopez Doldan, Carmen [2 ]
Duran-Pineiro, Goretti [1 ]
Fernandez-Montes, Ana [3 ]
Garcia-Gomez, Jesus [3 ]
Fernandez-Gonzalez, Maria Perfecta [2 ]
Salgado-Fernandez, Mercedes [3 ]
Paez, David [4 ,5 ,6 ]
Guino, Elisabet [7 ]
Lopez-Fernandez, Luis [8 ]
Rojas, Augusto [9 ]
Castells, Antoni [10 ]
Castellvi-Bel, Sergi [10 ]
Ruiz-Ponte, Clara [1 ,11 ]
Vymetalkova, Veronika [12 ]
Vodicka, Pavel [12 ]
Garcia de Santiago, Belen [13 ]
Lopez-Aspiroz, Elena [13 ]
Garcia-Mata, Jesus [3 ]
Carracedo, Angel [1 ,11 ]
Fernandez-Rozadilla, Ceres [1 ]
机构：
[1] Inst Invest Sanitaria Santiago, Santiago De Compostela, Spain
[2] Complexo Hosp Univ Ourense, Oncol Pharm, Orense, Spain
[3] Complexo Hosp Univ Ourense, Oncol, Orense, Spain
[4] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[5] Med Sci Innovat Res, Barcelona, Spain
[6] Univ Autonoma Barcelona, Barcelona, Spain
[7] Inst Catala Oncol, Barcelona, Spain
[8] Hosp Gen Univ Gregorio Maranon, Dept Pharm, Madrid, Spain
[9] Tecnol Monterrey, Sch Med & Hlth Sci, Monterrey, Mexico
[10] Inst Invest Biomed August Pi & Sunyer, Dept Gastroenterol, Barcelona, Spain
[11] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain
[12] Charles Univ Prague, Inst Biol & Med Genet, Prague, Czech Republic
[13] Hosp Univ Infanta Sofia, Hosp Pharm Serv, Madrid, Spain
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
EP19.003
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [31] DcR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer
    Mild, G
    Bachmann, F
    Boulay, JL
    Glatz, K
    Laffer, U
    Lowy, A
    Metzger, U
    Reuter, J
    Terracciano, L
    Herrmann, R
    Rochlitz, C
    INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (03) : 254 - 257
  • [32] TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy
    Chao, Yvonne L.
    Anders, Carey K.
    CLINICAL BREAST CANCER, 2018, 18 (03) : E301 - E304
  • [33] Selecting patients with stage II/III colorectal cancer for 5-fluorouracil-based adjuvant chemotherapy using proteomic analysis.
    Yan, Dongyao
    Hong, Ji Hyung
    Lee, Hee Yeon
    Byun, Jae Ho
    Cecchi, Fabiola
    Tian, Yuan
    Schwartz, Sarit
    An, Eunkyung
    Hembrough, Todd A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [34] Combination of polymorphisms between MTHFR and TS gene modulates survival after 5-fluorouracil-based therapy in colorectal cancer patients
    Kim, Jong Woo
    Lee, Jae Ho
    Hong, Seung Ho
    Yim, Dong Jin
    An, Hee Jung
    Chong, So Young
    Oh, Doyeun
    Kim, Nam Keun
    GENES & GENOMICS, 2010, 32 (05) : 469 - 475
  • [35] Combination of polymorphisms between MTHFR and TS gene modulates survival after 5-fluorouracil-based therapy in colorectal cancer patients
    Jong Woo Kim
    Jae Ho Lee
    Seung Ho Hong
    Dong Jin Yim
    Hee Jung An
    So Young Chong
    Doyeun Oh
    Nam Keun Kim
    Genes & Genomics, 2010, 32 : 469 - 475
  • [36] Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens
    Massacesi, C
    Pistilli, B
    Valeri, M
    Lippe, P
    Rocchi, MBL
    Cellerino, R
    Piga, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (02): : 140 - 148
  • [37] Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
    F Graziano
    A Ruzzo
    F Loupakis
    D Santini
    V Catalano
    E Canestrari
    P Maltese
    R Bisonni
    L Fornaro
    G Baldi
    G Masi
    A Falcone
    G Tonini
    P Giordani
    P Alessandroni
    L Giustini
    B Vincenzi
    M Magnani
    British Journal of Cancer, 2008, 99 : 716 - 721
  • [38] Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy
    Göran Carlsson
    Elisabeth Odin
    Bengt Gustavsson
    Yvonne Wettergren
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 757 - 763
  • [39] Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy
    Carlsson, Goran
    Odin, Elisabeth
    Gustavsson, Bengt
    Wettergren, Yvonne
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 757 - 763
  • [40] Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
    Graziano, F.
    Ruzzo, A.
    Loupakis, F.
    Santini, D.
    Catalano, V.
    Canestrari, E.
    Maltese, P.
    Bisonni, R.
    Fornaro, L.
    Baldi, G.
    Masi, G.
    Falcone, A.
    Tonini, G.
    Giordani, P.
    Alessandroni, P.
    Giustini, L.
    Vincenzi, B.
    Magnani, M.
    BRITISH JOURNAL OF CANCER, 2008, 99 (05) : 716 - 721
12345